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1. Introduction 
Oxaloacetate may be transported in rat liver mito- 
chondria (RLM) by the oxoglutarate carrier, which 
catalyzes the exchange between OAA and oxoglutarate 
(or some other dicarboxylates) [1,2]. Although the 
transport of OAA in rat heart mitochondria (RHM) 
may have an important role in the transfer of reducing 
equivalents from the mitochondria to cytosol [3], 
only preliminary and contradictory esults on OAA 
transport in heart mitochondria may be found. 
Whereas OAA causes efflux of intramitochondrial 
oxoglutarate [ 1], it is stated [4] that RHM are virtu- 
ally impermeable to OAA. This paper examines the 
transport of OAA in RHM and presents evidence that 
OAA is transported by the oxoglutarate carrier at 
significant rates and with high affinity. 
2. Materials and methods 
Bathophenanthroline sulph0nate, neocuproine, 
8-hydroxy-quinoline, p-hydroxymercuribenzoate, 
amino-oxy acetic acid and malic enzyme were obtained 
from Sigma; phthalonic acid was prepared as in [5]. 
Other eagents were obtained as in [1,6,7]. 
Rat heart mitochondria were isolated and, when 
indicated, loaded with [14C]oxoglutarate s in [1]. 
The loading procedure l ads to an intramitochondrial 
concentration f oxoglutarate of 5-8 mM. The 
kinetics of oxaloacetate/oxoglutarate nd oxo- 
glutarate/oxoglutarate exchanges were measured by 
the 'inhibitor stop' method essentially as applied to 
Abbreviations: OAA, oxaloacetate; RHM, rat heart mito- 
chondria; RLM, rat liver mitochondria 
RLM before [ 1,8]. [14C] oxoglutarateqoaded mito- 
chondria were incubated in 0.5 ml medium for 1 min 
under the condition specified in the legends. The 
assay was started by addition of unlabelled OAA or 
oxoglutarate and terminated 4-6 s later by rapid 
addition of 20 mM phenylsuccinate. During this 
period, the rate of exchange was constant within the 
limits of experimental error. After rapidly centrifuging 
the mitochondria in an Eppendorf microcentrifuge, 
the radioactivity in the pellets and supematants was 
measured [9]. In order to calculate the rate of the 
exchange, the amounts of radioactivity and oxo- 
glutarate,.present in the mitochondrial matrix and in 
the extramitochondrial phase prior the addition of 
the external substrate, were determined [1,8]. 
Changes in the redox state of intramitochondrial 
nlcotinamide nucleotides were followed by fluorimetry 
[10] usingan Eppendorfphotometer (Model 1101 M) 
equipped with appropriate filters. The mitochondrial 
protein was determined by a modified biuret method 
[ 11 ]. Oxol0utarate was measured fluorimetrically as
in [12]. For measuring the amount of oxoglutarate 
in the matrix the space available to 3H20 and [14C]- 
sucrose was determined, in parallel experiments, as
in [8,9]. 
3. Results 
In the extramitochondrial phase of RHM, sus- 
pended in an isoosmotic incubation medium, con- 
taining rotenone, the concentration f malate is 
neglegible, since the addition of malic enzyme does 
not reduce xternally-added NADP ÷ (not shown). If, 
however, NADP ÷ and malic enzyme are added to the 
mitochondrial suspension after OAA (which per se 
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Fig.1. Uptake of OAA by RHM and appearance of malate in 
the incubation medium. RHM (0.5 mg protein) were pre- 
incubated for 2 min in 1.0 ml medium containing 0.2 M 
sucrose, 10 mM KCI, 1 mM MgCI 2, 20 mM Hepes-Tris 
pH 7.0 and 1/zg rotenone at 25°C. Where indicated, additions 
were as follows: 100 tzM oxaloacetate (OAA), 30 ~M in (b) 
and 100 t~M in (c) phthalonate (PHTA), 250 I~M NADP + and 
0.1 units of malic enzyme (M.E.), previously dialyzed against 
100 mM Tris-HC1 buffer at pH 7.0. Nicotinamide nueleotide 
oxidation/reduction changes were followed fluorimetrically. 
( . . . . .  ) Tangent o the initial part of the progress curve of 
the reactions. The numbers assigned to the tangents are their 
slopes in arbitrary units of scale divisions/min. 
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Fig.2. Kinetic analysis of the inhibition ofoxaloacetate uptake 
by phthalonate using the double reciprocal plot (A) and the 
Dixon plot (B). RHM (0.8 mg and 1.1 mg protein in A and 
B, respectively) were preincubated for 2 min in 1.0 ml 
medium containing 0.2 M sucrose, 10 mM KC1, 1 mM MgC12, 
20 mM Hepes-Tris, pH 7.0 and 1 t~g rotenone at 25°C. In A, 
OAA was added at the concentrations indicated without 
(A) or with 10 ~M phthalonate (zx). In B, OAA was added at 
2 conc.: 50 t~M (o) and 250 ~M (e), and phthalonate at the 
concentrations indicated. The inset in B is a replot of the 
data, where i = 1 - Fi/Y, and F i and Y are the rates of 
NAD(P)H oxidation in the presence and absence of phthalo- 
nate, respectively. The rate of NAD(P)H oxidation was 
followed fluorimetrically. 
causes a fast oxidation of intramitochondrial 
NAD(P)H), a rapid and extensive reduction of pyridine 
nucleotides occurs (fig. 1). Neither NADP ÷ nor malic 
enzyme have any effect when added alone. These 
results imply the appearance of malate in the phase 
outside the mitochondria during the incubation of 
the mitochondria with OAA. A possible explanation 
of these results is that oxaloacetate is taken up in 
exchange of a small amount of oxoglutarate (or 
malate) via the oxoglutarate carrier. Inside the mito- 
chondria, the OAA would be reduced-to malate, 
which in turn could be exchanged for further OAA. 
The use of the oxoglutarate carrier by oxaloacetate is 
demonstrated bythe sensitivity of oxaloacetate uptake 
to phthalonate, which is a specific inhibitor of the 
oxoglutarate carrier [13]. As shown in fig.l, 
phthalonate inhibits both the uptake of OAA and the 
efflux of  malate. The nature of the inhibition on 
oxaloacetate uptake was studied by varying the 
oxaloacetate concentration atless than fully inhibitory 
amounts of phthalonate. The results, illustrated as a 
double reciprocal plot (fig.2A), suggest that the 
inhibition is competitive (oxaloacetate uptake K m 
20/aM;K i 1/aM). This is further evidenced by a Dixon 
plot (fig.2B). The inset in which the reciprocal plots 
of the fractional inhibition (i) against inhibitor con- 
centrations are reported, as advised [14], shows that 
linear functions are obtained which intersect the 
ordinate at unity, indicating that phthalonate is a 
completely competitive inhibitor with respect o 
oxaloacetate entry into RHM. In experiments not 
shown it was found that another inhibitor of the oxo- 
glutarate carrier, i.e., phenylsuccinate [6,15], inhibits 
oxaloacetate entry into RHM in a competitive manner 
(K i 15/aM). In agreement With the use of the oxo- 
glutarate carrier, oxoglutarate was also shown to be a 
competitive inhibitor of OAA transport (K i 15/aM). 
Vice versa, it was found that OAA inhibits the rate 
of oxoglutarate oxidation in RHM competitively, 
with K i 40 pM. 
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Fig.3. The dependence of the rate of the oxaJoacetate/oxo- 
glutarate and oxoglutarate/oxoglutarate exchanges on the 
external substrate concentration. Mitochondxia loaded with 
[14C]oxoglutarate (0.6 mg protein) were incubated at 8°C in 
0.5 ml medium containing 0.2 M sucrose, 10 mM KCI, 1 mM 
MgCI 2 , 20 mM Hepes-Tris, pH 7.0, 1 pg rotenone and 2 mM 
arsenite. The assay was started with oxaloacetate or oxogluta- 
rate at the concentrations indicated, and stopped after 6 s 
by addition of 20 mM phenylsuccinate. (zs) oxaloacetate/oxo- 
glutarate exchange; (A) oxoglutarate/oxoglutarate exchange. 
v is expressed as pmol/min/g protein. Other conditions were 
as in section 2. 
In view of the lack of labelled oxaloacetate, the 
kinetics of oxaloacetate exchange were measured by 
following the efflux of [14C]oxoglutarate from oxo- 
glutarate-loaded mitochondria. For comparative 
purposes the kinetics of the oxoglutarate/[14C] oxo- 
glutarate xchange were also measured. The data 
from a typical experiment (fig.3) show that, with 
both substrates, linear functions are obtained, whose 
intersections with the ordinate are very close. This 
can be interpreted to show that Vma x for the rate of 
oxaloacetate and oxoglutarate uptake is the same 
(approx. 18 tnnol/min X g protein at 8°C). The slopes, 
however, are different, i.e., the K m is higher for 
oxaloacetate han for oxoglutarate. In this experi- 
ment, the oxoglutarate K m is 13/aM and OAA K m is 
50/aM. 
The specificity of oxaloacetate ransport in rat 
heart mitochondria was investigated by studying the 
effect of various anions on the rate of oxaloacetate 
Table 1 
Effect of various anions, thiol reagents and metal-complexing 
agents on oxaloacetate uptake by heart mitochondria 
Additions Inhibition (%) 
Malonate 45 
Oxomalonate 60 
Aminomalonate 3 
Glutarate 28 
Oxoglutarate 100 
Glutamate 0 
Aspartate 7 
Phosphate 16 
Sulphate 5 
Thiosulphate 13 
Mersalyl 100 
p-Hydroxymercuribenzoate 33 
N-ethylmaleimide 0 
Bathophenanthroline 100 
Neocuproine 44 
8-Hydroxy-quinoline 42 
RHM (0.6 mg protein) were added to 1 ml medium contain- 
ing 0.2 M sucrose, 10 mM KCI, 1 mM MgC12, 20 mM Hepes- 
Tris, pH 7.0, 1 pg rotenone and 2 mM arsenite at 25°C. 
After 2 min, the reaction was started by the addition of 
100 pM OAA. The additions, indicated in the table, were 
made simultaneously with OAA at 0.1 mM concentration, 
except NEM which was 0.56 mM. In the samples where the 
effect of aminoacids was tested, 2 mM aminooxyacetate was 
also included in the incubation mixture. The results are given 
as % inhibition NAD(P)H oxidation rate, measured fluori- 
metrically 
uptake. As reported in table 1, dicarboxylates and 
oxodicarboxylates inhibit to a considerable degree 
the OAA-induced oxidation of intramitochondrial 
nicotinamide nucleotides. On the other hand, amino- 
dicarboxylates and other anions such as phosphate 
and sulphate, do not cause significant effect. It 
should be noted that the aminodicarboxylates gluta- 
mate and aspartate were ineffective in the presence 
and in the absence of 2 mM aminooxyacetate, a 
competitive inhibitor of the mitochondrial spartate- 
aminotransferase [16]. Table 1 also shows that the 
uptake of OAA by RHM is inhibited by the metal- 
complexing agents bathophenathroline, ocuproine 
and 8-hydroxy-quinoline, as well as by certain thiol 
reagents, like mersalyl and p-hydroxymercuribenzoate, 
but not N-ethylmaleimide. All these properties are 
distinctive features of the oxoglutarate carrier in 
RLM [6,17]. 
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4. Discussion 
The present results give evidence that the transport 
of OAA in RHM is mediated by the oxoglutarate 
carrier. Furthermore, by comparing the data reported 
in this paper with those obtained for RLM [1], it is 
clear that OAA is transported in RHM much more 
effectively than in RLM. Whereas in the latter the 
K m for OAA transport (approx. 1 mM) is much higher 
than the concentrations of free OAA in the intact cell 
[18,19], the K m for OAA transport in RHM (approx. 
40 taM) is comparable with the cytosolic oncentra- 
tions of OAA in heart (50/aM or more under some 
conditions [20] ). The rate of OAA uptake in RI-IM 
extrapolated to37°C with an activation energy about 
20 kcal/mol is 760/amol/min × g protein. It is 
apparent that he kinetic parameters of OAA transport 
in RHM are compatible with the possibility that an 
oxaloacetate influx and malate fflux via the oxo- 
glutarate (either by a direct exchange or by a com- 
bined OAA/oxoglutarate and oxoglutarate/malate 
exchange) may account for the efflux of reducing 
equivalents from mitochondria inheart perfused with 
pyruvate [3]. Furthermore, in heart, the OAA/malate 
exchange would seem the only alternative for transfer 
of reducing equivalents o the cytosol, since the 
malate-aspartate cycle is unidirectional [21] and 
heart muscle does not contain sufficient pyruvate 
carboxylase and phosphopyruvate carboxykinase for 
the hepatic pyruvate--malate shuttle [22] to operate. 
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